HAVCR2 and head and neck cancer: In the context of human cancer, it was previously reported that PD-1+ Tim-3+ CD8+ TILs expressed higher EOMES transcripts than PD-1−Tim-3− CD8+ TILs in head and neck cancer patients (34).